Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

DNA vaccines offer promising strategies for immunization against infections. However, their clinical use requires improvements in immunogenicity. We explored the efficacy of Toll-like receptor (TLR) ligands (TLR-Ls) on augmenting the immunogenicity of a DNA prime–modified vaccinia virus Ankara (MVA)...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kwissa, Marcin, Amara, Rama R., Robinson, Harriet L., Moss, Bernard, Alkan, Sefik, Jabbar, Abdul, Villinger, Francois, Pulendran, Bali
Formaat: Artikel
Taal:English
Gepubliceerd in: The Rockefeller University Press 2007
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2118478/
https://ncbi.nlm.nih.gov/pubmed/17954572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20071211
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2118478/
https://ncbi.nlm.nih.gov/pubmed/17954572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20071211

Gelijkaardige items